Metabolomics Market Geographic Analysis - Global Forecast

[286 Pages Report] The global Metabolomics Market is expected to reach USD 2,386.4 million by 2021 from USD 1,209.4 million in 2016, at a CAGR of 14.6% during the forecast period.

Metabolomics Market is a powerful and unique analytical approach for the systematic identification and quantification of small-molecule metabolites, metabolite target analysis, metabolic profiling, and metabolic fingerprinting in various biological systems and samples.

Don’t miss out on business opportunities in Metabolomics Market.

Metabolomics Market majorly comprises detection techniques such as mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR), and separation techniques such as gas chromatography. These techniques are used in metabolome studies, primarily in toxicology testing and developing personalized medicine.

Geographic Analysis:

• Further country-wise breakdown of the Rest of Asia-Pacific Metabolomics Market into South Korea, Australia, New Zealand, and others
• Further country-wise breakdown of the Latin American Metabolomics Market into Brazil, Argentina, and Rest of Latin America

Key Questions Answered In This Research Report:

• Metabolomics helps identify the type and number of compounds analyzed by making use of several complementary analytical methods and what would be the future of metabolomics instruments in the upcoming years?
• How growing demand for personalized medicine and other factors would change the future of Metabolomics Market?

Browse and in-depth TOC on “Metabolomics Market”

188 — Tables

42 — Figures

286 — Pages

Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=900

Objectives of the Study;

• To define, describe, and forecast the global Metabolomics Market on the basis of product & service, application, indication, and region
• To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of the Metabolomics Market with respect to North America, Europe, Asia- Pacific, Latin America, and the Middle East & Africa

Request for Free Sample Report @

https://www.marketsandmarkets.com/pdfdownload.asp?id=900

Growing Demand for Personalized Medicine Drive the Metabolomics Market;

The growing focus on personalized medicine has driven the use of metabolomics tools by manufacturers engaged in developing rigorous strategies for understanding the root of a disease rather than simply treating a patient’s symptoms. Recent developments in analytical technologies, such as the emergence of high-resolution mass spectrometry, have provided revolutionary analytical capabilities in metabolomics, offering the detection of more than 10,000 metabolites at a given point of time.

Such developments are opening new opportunities for the utilization of metabolomics in the development of personalized and precision medicine. Considering significant developments in the field of metabolomics, coupled with the increasing focus of industry participants to leverage the advantages of metabolomics approaches in the development of personalized medicine, the market is expected to witness significant growth in the coming years.

Sugar-Based Excipients Market 2019 Geographical Segmentation

The increasing use of co-processed excipients to improve the dissolution, bioavailability, and solubility of recently developed active pharmaceutical ingredients (APIs), rapid growth in the generics market due to the patent expiration of many blockbuster drugs and increasing development of orally disintegrating tablets (ODT) are expected to propel the growth of this market.

The global Sugar-Based Excipients Market is segmented on the basis of product, type, functionality, formulation, and region.

Don’t miss out on business opportunities in Sugar-Based Excipients Market

Geographically, the global Sugar-Based Excipients Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, Europe commanded a major share of the global market. Europe’s largest share is primarily attributed to the increasing investments in drug development, increasing the production of generic drugs, and favorable government initiatives in the region. North America, represents the second largest market for sugar excipients. 

Factors such as the presence of a large number of global pharmaceutical companies and increasing demand of generic drugs due to patent expiration of blockbuster drugs are majorly contributing to the growth of the market in this region. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the significant growth in the regional healthcare market as well as the pharmaceutical industry, growing scientific base and capability, and favorable government policies, and low-cost manufacturing advantages in this region.

Download PDF (Sugar Excipients Market):

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=242342136

Medical Supplies Market overview of the major drivers, restraints, challenges, opportunities

The Medical Supplies Market by type is expected to reach USD 136.63 Billion, at a CAGR of 6.8% 

The Research Report on Medical Supplies Market by type provides a detailed overview of the major drivers, restraints, challenges, opportunities, and strategies impacting the global Medical Supplies Market along with the estimates and forecasts of the revenue and market share analysis.

Don’t miss out on business opportunities in Medical Supplies Market by type

The major factors driving the growth of this market are the rising geriatric population, increasing incidence of various diseases, and the rising number of surgeries.

This report segments the Medical Supplies Market by type on the basis of type, application, end user, and region.

Based on the type, the market is segmented into diagnostic supplies, dialysis consumables, wound care consumables, inhalation products, radiology consumables, infection control supplies, infusion products, intubation and ventilation supplies, personal protective equipment (PPE), hypodermic products, sterilization consumables, and other supplies.

Browse and in-depth TOC on “Medical Supplies Market”

157 — Tables

76 — Figures

212 — Pages

Speak To Analyst:https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=64344238

Based on application, the market is segmented into urology, wound care, radiology, anesthesia, sterilization, cardiology, ophthalmology, and other applications. The anesthesia segment is expected to register the highest growth during the forecast period. The high growth in this segment is attributed to the increasing number of surgical procedures being performed across the globe and the rising incidence of respiratory diseases.

Based on end user, the market is segmented into hospitals, clinics, assisted living centers and nursing homes, ambulatory surgery centers (ASCs), and other end users. The hospitals segment is expected to register the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing investment in healthcare systems, growing prevalence of HAIs, and high incidence of chronic diseases across the globe.

Request for Free Sample Report @https://www.marketsandmarkets.com/requestsample.asp?id=64344238

On the basis of region, the Medical Supplies Market by type is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is projected to be the fastest-growing region in the forecast period, owing to factors such as the rising geriatric population, increasing incidence of various diseases, growing medical tourism industry, and improving healthcare infrastructure.

The key players in the Medical Supplies Market by type include Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (U.S.), Cardinal Health, Inc. (U.S.), Halyard Health, Inc. (U.S.), Johnson & Johnson (U.S.), Thermo Fisher Scientific Inc. (U.S.), Boston Scientific Corporation (U.S.), Baxter International Inc. (U.S.) and 3M Company (U.S.).

4 thoughts on Prefilled Syringes Market Overview | Growth Drivers | Restraints | Opportunities and Trends | Insights by Geography | Competitive Landscape

The Global Prefilled Syringes Market is expected to reach USD 6.36 Billion, at CAGR of 10.1%.

According to the new market research report “Prefilled Syringes Market by Material (Glass, Plastic), Type (Conventional, Safety), Design (Dual & Single-Chamber, Customized ), Region (North America (U.S.), Europe (Germany, UK, France), Asia-Pacific (Japan, India, China)) — Forecast to 2021”, published by MarketsandMarkets™.

Don’t miss out on business opportunities in Prefilled Syringes Market by Material

Speak to our analyst and gain crucial industry insights that will help your business grow:

https://www.marketsandmarkets.com/speaktoanalyst.asp?id=16618331

Factors driving the growth of this market include technological advancements in prefilled syringes, high prevalence of chronic diseases, presence of a large patient population base, rising adoption of self-injection devices, and implementation of needlestick legislations. In addition, initiatives undertaken by leading market players (such as Gerresheimer AG, SCHOTT AG, and Becton, Dickinson and Company) to establish production facilities in both mature and developing markets have further added to the growth prospects of this market. However, lack of safety features in prefilled syringes and product recalls are expected to limit the growth of this market in the coming years.

Browse and in-depth TOC on “Prefilled Syringes Market by Material”

85 — Tables

41 — Figures

130 — Pages

On the basis of type, the Prefilled Syringes Market by Material is segmented into conventional prefilled syringes and safety prefilled syringes. The conventional prefilled syringes segment is expected to account for the largest share during the forecast period. This growth can be primarily attributed to the comparatively low penetration of safety syringes.

On the basis of design, the Prefilled Syringes Market by Material is further segmented into single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes. The single-chamber prefilled syringes market is expected to command the largest share of the global prefilled syringes market in 2016. The increasing adoption of self-administered parenteral drugs is the key factor responsible for the growth of the single-chamber prefilled syringes market.

Request for Free Sample Report @https://www.marketsandmarkets.com/requestsample.asp?id=16618331

Europe is expected to hold the largest share of the Global Prefilled Syringes Market by Material, followed by North America. However, the Asia-Pacific market is expected to grow at the highest CAGR. Factors such as increasing demand for self-administered treatments, high penetration of self-injection devices, growing the aging population, increasing the prevalence of diabetes, and huge patient population is driving the growth of prefilled syringes in the Asia-Pacific region.

key players operating in the Prefilled Syringes Market:

Becton, Dickinson and Company (U.S.), Gerresheimer (Germany), SCHOTT AG (Germany), West Pharmaceutical Services, Inc. (U.S.), Ompi (Italy), Catalent, Inc. (U.S.), Weigao Group (China), Vetter Pharma International GmbH (Germany), Nipro Corporation (Japan), and MedPro Inc. (U.S.)

Press Release published on Prefilled Syringes Market:

https://www.marketsandmarkets.com/PressReleases/prefilled-syringes.asp

Global Antinuclear Antibody Test Market Analysed by Size, Share and Forecast

The Global Antinuclear Antibody Test Market is expected to reach USD 1,476.1 Million, at a CAGR of 12.4%.

According to the new market research report “Antinuclear Antibody Test Market by Product (Reagents & Assay Kits, Systems, Software, Services), Technique (Immunofluorescence, Elisa, Multiplex), Disease (Rheumatoid Arthritis, SLE), End User (Clinical Labs, Hospitals) — Forecast to 2021”, published by MarketsandMarkets™.

Don’t miss out on business opportunities in Antinuclear Antibody Test Market

     Antinuclear Antibody Test Market

The Antinuclear Antibody Test Market research report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the ANA testing market, along with revenue estimates & forecasts and market share analysis.

Download PDF ( ANA Test Market ):

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64344238

The increasing prevalence of autoimmune diseases and increasing healthcare expenditure worldwide are the major factors driving the growth of this market.

This market is segmented based on products, diseases, techniques, end users, and regions.

On the basis of products, the ANA testing market is segmented into assay kits & reagents, systems, and software & services. The assay kits & reagents segment are expected to account for the largest share of the global market in 2016, primarily due to the growing number of reagent rental agreements and the increasing prevalence of autoimmune diseases worldwide.

Browse and in-depth TOC on “Antinuclear Antibody Test Market”

73 — Tables

102 — Figures

166 — Pages

Speak To Analyst:

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=64344238

Based on techniques, the Antinuclear Antibody Test Market is segmented into three broad segments, namely, enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), and multiplex assay. The ELISA segment is expected to account for the largest share of this market owing to expanding applications of ANA in autoimmune disease testing and therapeutic drug level monitoring.

The Global antinuclear antibody test market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to dominate the global market in the forecast period. However, Asia is expected to witness the highest growth in the coming years, with the growth in this regional segment centered at China, Japan, and India.

Request Sample of Research Report:https://www.marketsandmarkets.com/requestsampleNew.asp?id=218189007

Key players in the Antinuclear Antibody Test Market include Alere Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), ERBA Diagnostics, Inc. (U.S.), Trinity Biotech plc (Ireland), Thermo Fisher Scientific, Inc. (U.S.), Antibodies, Inc. (U.S.), EUROIMMUN AG (Germany), Immuno Concepts (U.S.), Inova Diagnostics (U.S.), and Zeus Scientific, Inc. (U.S.).

Rehabilitation Equipment Market Analysis, Segments, Key Players, Drivers, Trends and Forecast

The global Rehabilitation Equipment Market is expected to reach 14.91 Billion by 2021 from USD 9.86 Billion, at a CAGR of 8.6% during the forecast period.

According to the new market research report “Rehabilitation Equipment Market by Type (Mobility (Wheelchair, Assist Device), Body Support (Lift, Sling), Exercise (Upper, Lower Body), Living Aids (Reading, Writing)), Application (Physiotherapy, OT), End User (Hospital, Clinic, Home Care) — Forecasts to 2021”, published by MarketsandMarkets™.

Don’t miss out on business opportunities in Rehabilitation Equipment Market.

This Research Report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Home care settings form the fastest growing end-user segment.

The dominance of this segment in the rehabilitation equipment market is mainly attributed to the higher quality of treatment provided in hospitals and clinics, as opposed to other end-user segments. Developments in healthcare systems and competition between hospital-based rehabilitation service providers, which have enhanced the quality of care provided, have also contributed to market growth. The growth of the elderly and disabled populations, who are completely dependent on caregivers for daily activities, is another key driver of market growth for this segment.

Browse and in-depth TOC on “Rehabilitation Equipment Market”

154 — Tables

31 — Figures

162 — Pages

View more detailed TOC @

https://www.marketsandmarkets.com/Market-Reports/rehabilitation-equipment-market-194775519.html

Increasing incidence of disabilities, and rapid growth in the geriatric population are the major drivers for the market.

The key causes of disabilities are non-communicable diseases and injuries such as sports injuries, trauma cases and various other injuries. Non-communicable diseases (NCDs) or chronic diseases are generally of long duration and slow progression.

There are four major types of NCDs — cardiovascular disease (such as heart attacks and stroke), cancers, chronic respiratory disease (such as chronic obstructive pulmonary disease and asthma), and diabetes. NCDs are considered the leading cause for preventable disabilities such as paralysis and mental disorders among the patients. The rising incidence of NCDs has correspondingly boosted cases of disability among patients; this is expected to drive the demand for rehabilitation equipment.

Request for Free Sample Report @

https://www.marketsandmarkets.com/requestsample.asp?id=194775519

The Rehabilitation Equipment Market is fragmented in nature with several big and emerging players. This market is dominated by key players such as Invacare Corporation (U.S.), Medline Industries, Inc. (U.S.), Dynatronics Corporation (U.S.), Drive DeVilbiss Healthcare (U.S.), Changzhou Qian Jing Rehabilitation Co., Ltd. (China), Carex Health Brands (U.S.),

Veterinary Chemistry Analyzer Market Analysis, Segments, Key Players, Drivers, Trends and Forecast

[250 Pages Report] The Global Veterinary Chemistry Analyzer Market is estimated to grow at a CAGR of 8.7%, to reach USD 1,205.2 Million by 2022. the Veterinary Chemistry Analyzer Market is segmented on the basis of product, application, animal type, and region.

In this report, On the basis of products, the market is segmented into instruments (including chemistry analyzers, urine analyzers, glucometers, and blood gas & electrolyte analyzers) and consumables (including panels, kits, test strips, and reagents).

Ask For Discount:https://www.marketsandmarkets.com/discountreports.asp?id=48798056

The Veterinary Chemistry Analyzer Market is further segmented, on the basis of animal type, into companion animals and livestock. In 2016, the companion animal segment accounted for the largest share of the market. This segment is also expected to register the highest growth during the forecast period.

Browse and in-depth TOC on “Veterinary Chemistry Analyzer Market”

206 — Tables

24 — Figures

250 — Pages

View more detailed TOC @

https://www.marketsandmarkets.com/Market-Reports/veterinary-chemistry-analyzer-market-48798056.html

The report also provides a detailed geographic analysis of the Veterinary Chemistry Analyzer Market covering developed and emerging economies. The developed market includes the U.S., Canada, Germany, the U.K., France, Italy, Spain, and Japan while the emerging market includes China, India, and Latin America. In 2016, the U.S. attributed the largest share of the developed market owing to its well-established animal healthcare systems.

The emerging market is expected to register the highest CAGR, owing to growing animal population, increasing demand for animal-derived food products, rising awareness about animal health and welfare, and growing per capita animal health expenditure, especially in Latin America, India, and China.

Depth Filtration Market Growth and Analysis, Industry Trends, Size, Shares, Forecast

The Global Depth Filtration Market is poised to reach USD 2.96 Billion by 2022 from USD 1.70 Billion in 2017, at a CAGR of 11.7%.

Browse 71 market data Tables and 29 Figures spread through 127 Pages and in-depth TOC on “Depth Filtration Market”

http://www.marketsandmarkets.com/Market-Reports/depth-filtration-market-143876285.html

The report provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue.

The growth in this market will majorly be driven by the increasing production of biologics and large molecules, as depth filtration plays a significant role in providing pure and quality products. Depth filters offer advantages such as low cost and ease of use; these advantages are driving their uptake in the market. However, low capacity of depth filters for high-density harvest is a key challenge in this market.

Speak To Analyst:http://www.marketsandmarkets.com/speaktoanalyst.asp?id=143876285

Furthermore, based on application, the depth filtration market is categorized into final product processing, cell clarification, raw material filtration, and other applications. In 2017, final product processing segment is expected to account the largest share of the global depth filtration market. The final product processing segmented is further divided into small molecule processing and biologics processing. The large share of the final product processing segment is attributed to the rapid growth in the biopharmaceutical industry, expansion in generics production, and the need for high-quality final products.

North America (comprising the U.S. and Canada) is expected to account for the largest share of the global depth filtration market in 2017, followed by Europe. North America is the world’s largest pharmaceutical market and a leader in biopharmaceutical research. Rising quality requirements have emphasized the need for advanced bioproduction technology in this region. Asia-Pacific is expected to grow at the highest CAGR in the forecast period. Significant investments by key market players, increasing government support, developing R&D infrastructure, and growing expertise and academic excellence are the major factors fueling the growth of the depth filtration market in the Asia-Pacific region.

Download PDF Brochure@http://www.marketsandmarkets.com/pdfdownload.asp?id=143876285

The depth filtration market is dominated by established players such as Merck KGaA (Germany), Sartorius Stedim Biotech S.A. (France), and Pall Corporation (U.S.).

Oxygen Therapy Equipment Market Analysis, Segments, Key Players, Drivers, Trends and Forecast

The Oxygen Therapy Equipment Market is expected to reach USD 4.01 Billion by 2022 from USD 2.65 Billion in 2017, at a CAGR of 8.7% from 2017 to 2022.

According to a new market research report “Oxygen Therapy Equipment Market by Product (Oxygen Source (Concentrator, Cylinder), Delivery Devices), Portability (Stationary, Portable), Application (COPD, Asthma, Cystic Fibrosis, Pneumonia), End User (Hospital, Home Care) — Global Forecast to 2022”, published by MarketsandMarkets™.

Browse 148 market data tables and 46 figures spread through 175 pages and in-depth TOC on “Oxygen Therapy Equipment Market”

http://www.marketsandmarkets.com/Market-Reports/oxygen-therapy-equipment-market-118828572.html

Factors driving the growth of this market are the increasing prevalence of respiratory disorders, rapid growth in the geriatric population, prevalence of tobacco smoking, preference towards home-based oxygen therapy, and technological advancements to develop novel products delivering oxygen therapy.

Oxygen source equipment is expected to dominate the market in 2017

On the basis of products, the Oxygen Therapy Equipment Market is segmented into oxygen source equipment and oxygen delivery devices. The oxygen source equipment segment is expected to dominate the global Oxygen Therapy Equipment Market in 2017. The increasing incidence of respiratory disorders and technological advancements to develop smaller, quieter and more effective equipment are key drivers increasing the demand for oxygen source equipment.

Download PDF Brochure:http://www.marketsandmarkets.com/pdfdownload.asp?id=118828572

Stationary oxygen therapy devices are estimated to command the largest market share in 2017

The Oxygen Therapy Equipment Market is segmented by portability into stationary devices and portable devices. In 2017, the stationary devices segment is expected to account for the largest share of the Oxygen Therapy Equipment Market, by portability. Severe complications in patients suffering from respiratory disorders and the increasing proportion of geriatric population across the globe are major drivers for the growth of this segment.

North America to account for the major market share in 2017

Based on region, the Oxygen Therapy Equipment Market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is expected to dominate the Oxygen Therapy Equipment Market in 2017 on account of the increasing proportion of the geriatric population, rising number of hospitals, and increasing awareness regarding oxygen therapy.

Talk To Our Research Analysts:http://www.marketsandmarkets.com/speaktoanalyst.asp?id=118828572

Key players in the Oxygen Therapy Equipment Market include Philips Healthcare (Netherlands), Linde Healthcare (Germany), Chart Industries, Inc. (U.S.), Invacare Corporation (U.S.), Becton, Dickinson and Company (U.S.), Smiths Medical (U.S.), Drägerwerk AG & Co. KGaA (Germany), Teleflex Incorporated (U.S.), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Taiyo Nippon Sanso Corporation (Japan),